The report provides a detailed analysis essential for establishing a remdesivir production plant. It encompasses all critical aspects necessary for remdesivir production, including the cost of remdesivir production, remdesivir plant cost, remdesivir production costs, and the overall remdesivir production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a remdesivir production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Remdesivir is a broad-spectrum antiviral medication used to treat COVID-19 in hospitalized patients. It is also used in clinical trials and research studies to learn more about its efficacy against other viral infections. Moreover, it also finds application in studies related to improved drug delivery mechanism to enhance its bioavailability.
The market for remdesivir is majorly driven by its application for its positive effects in the treatment of COVID-19, which contributes to its market growth and increased demand in the medical and pharmaceutical industries. Moreover, its usage for research and clinical trials further enhances its demand in the biomedical, research, medical, and drug delivery research industries. Additionally, several factors influence industrial remdesivir procurement, such as the source and purity, cost and pricing, compliance with pharmaceutical regulations, quality standards, technological advancements, environmental considerations, sustainability practices, distribution (including trading and shipping), logistics, safety standards, etc.
Raw Material for Remdesivir Production
According to the Remdesivir production plant project report, the major raw material for Remdesivir production includes Variant of Phosphotriesterase from Pseudomonas diminuta.
Production Process of Remdesivir
The extensive Remdesivir production cost report consists of the following industrial production process:
- Production via Chemoenzymatic Strategy: This method of producing remdesivir involves the use of a chemoenzymatic strategy, which constitutes an In1W variant of phosphotriesterase from Pseudomonas diminuta (In1W-PTE) to synthesize a key intermediate with a 97% yield. Further, RP-Remdesivir is synthesized using t-BuMgCl-mediated coupling conditions.
Remdesivir is an antiviral medication formulated by a biopharmaceutical company. It is used to treat coronavirus disease. The molecular formula of Remdesivir is C27H35N6O8P, and its molecular weight is 602.58 g/mol. It is white to off-white in appearance. Remdesivir is slightly soluble in water but is completely soluble in dimethyl sulfoxide (DMSO), methanol, and ethanol. Remdesivir is a medication that binds to the viral RNA-dependent RNA polymerase and inhibits the replication of the virus. It is stable under recommended storage conditions (protected from light and moisture); however, it should be handled carefully to avoid degradation.